Daniel Le Sueur Health Catalyst, Inc. (HCAT) insider trading activity

Daniel Le Sueur is Chief Operating Officer of Health Catalyst, Inc.. Currently has a direct ownership of 198,367 shares of HCAT, which is worth approximately $450,293. The most recent transaction as insider was on Sep 02, 2025, when has been sold 3,663 shares (Common Stock) at a price of $3.36 per share, resulting in proceeds of $12,307. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 198K

0% 3M change

66.37% 12M change

Total Value Held $450,293

Daniel LeSueur Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 02 2025	SELL Payment of exercise price or tax liability	$12,307 $3.36 p/Share	3,663 Reduced 1.81%	198,367 Common Stock
Jun 02 2025	SELL Payment of exercise price or tax liability	$13,801 $3.63 p/Share	3,802 Reduced 1.85%	202,030 Common Stock
May 05 2025	SELL Open market or private sale	$21,356 $4.1 p/Share	5,209 Reduced 2.47%	205,832 Common Stock
Apr 03 2025	SELL Open market or private sale	$21,617 $4.15 p/Share	5,209 Reduced 2.41%	211,041 Common Stock
Mar 05 2025	SELL Open market or private sale	$76,397 $4.52 p/Share	16,902 Reduced 7.25%	216,250 Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$42,282 $4.58 p/Share	9,232 Reduced 3.81%	233,152 Common Stock
Feb 20 2025	BUY Grant, award, or other acquisition	-	156,340 Added 39.21%	242,384 Common Stock

Feb 05 2025	SELL Open market or private sale	$30,003 $5.76 p/Share	5,209 Reduced 5.71%	86,044 Common Stock
Jan 06 2025	SELL Open market or private sale	$39,119 $7.51 p/Share	5,209 Reduced 5.4%	91,253 Common Stock
Dec 04 2024	SELL Open market or private sale	$175,352 $7.7 p/Share	22,773 Reduced 19.1%	96,462 Common Stock
Dec 01 2024	SELL Payment of exercise price or tax liability	$93,781 $8.97 p/Share	10,455 Reduced 8.06%	119,235 Common Stock
Nov 05 2024	SELL Open market or private sale	$40,109 $7.7 p/Share	5,209 Reduced 3.86%	129,690 Common Stock
Oct 03 2024	SELL Open market or private sale	$40,005 $7.68 p/Share	5,209 Reduced 3.72%	134,899 Common Stock
Sep 04 2024	SELL Open market or private sale	$61,678 $7.58 p/Share	8,137 Reduced 5.49%	140,108 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$12,802 $7.27 p/Share	1,761 Reduced 1.17%	148,245 Common Stock
Aug 05 2024	SELL Open market or private sale	$32,243 $6.19 p/Share	5,209 Reduced 3.36%	150,006 Common Stock
Jul 03 2024	SELL Open market or private sale	$32,029 $6.15 p/Share	5,208 Reduced 3.25%	155,215 Common Stock
Jun 06 2024	SELL Open market or private sale	$80,122 $6.72 p/Share	11,923 Reduced 6.92%	160,423 Common Stock
Jun 03 2024	SELL Payment of exercise price or tax liability	$12,230 $6.53 p/Share	1,873 Reduced 1.08%	172,346 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$26,395 $8.05 p/Share	3,279 Reduced 3.05%	104,219 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	70,000 Added 28.66%	174,219 Common Stock

Daniel Le Sueur

Chief Operating Officer

South Jordan, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCAT shares.

Notify only if

Value

Insider Trading

Get notified when an Health Catalyst, Inc. insider buys or sells HCAT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Health Catalyst, Inc.

Track Activities on HCAT

Account